Jane Street’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Jane Street’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-44,200	Closed	-$1.22M	–	11207
2021 Q2	$1.22M	Buy	44,200 +7,500	+20%	+$147K	﹤0.01%	5397
2021 Q1	$605K	Buy	+36,700	New	+$836K	﹤0.01%	6459
2020 Q4	–	Sell	-14,800	Closed	-$201K	–	8417
2020 Q3	$201K	Buy	+14,800	New	+$228K	﹤0.01%	6430

Jane Street's TBIO Position: Q3 2021 in Review

Jane Street sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 94,733 shares — an estimated $2.61M sold.

Jane Street first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $2.61M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Jane Street reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Jane Street sold 94,733 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2.61M.
Jane Street first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Jane Street's Translate Bio, Inc. Common Stock position peaked at $2.61M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Jane Street's 13F filing for Q3 2021, filed 16 Nov 2021.